PlGF has been extensively studied in pregnancy and cancer, with the question of whether PlGF can provide an alternative to anti-angiogenic therapy, which encounters issues, such as refractory patients and acquired resistance, a phenomenon that also occurs in the treatment of retinal diseases. Here, PGF is linked to Abnormal retinal morphology.